Ischemic and Bleeding Outcomes After Angiolite Stent Implantation and an Abbreviated Dual Antiplatelet Therapy

To be considered for this study, you need to be an adult between 18 and 95 years old. You must also have at least one narrowing in a heart blood vessel (either a natural one or a bypass graft) that doctors think can be treated with a stent. The narrowed blood vessel needs to be at least 2mm wide. Most importantly, you must be willing to understand the study and agree to take part.

There are certain reasons why you wouldn't be able to join. For example, if you're allergic to any of the medications or materials used in the stents. You can't have severe liver problems or have had a heart procedure or major bleeding in the last 30 to 45 days. If you're planning non-heart surgery soon after getting a stent, or any heart surgery, you might not be eligible. Also, if you've had a stroke recently or are already in another main clinical trial, you wouldn't be able to join. Women who could become pregnant might not be able to participate unless they've had certain procedures to prevent pregnancy.

Basically, the study is looking for people with specific heart vessel narrowings who are generally well enough to undergo the procedures and take the study medications, without other major health issues that could interfere with the results or your safety.

If you join this study, you'll be assigned to receive either an Angiolite or a Xience stent, and either 1 month or 12 months of anti-clotting medication (doctors will know which you receive). You'll have your stent procedure and then follow-up appointments. The main part of the study will involve monitoring your health for 12 months after your stent procedure. During this time, the study team will check for any complications, especially related to bleeding or how well the stent is working. You will have regular checks, which might include clinic visits or phone calls, to make sure you are doing well.